Haier_Biomedical Achieves Double No. 1 Ranking

Haier Biomedical has secured a double No. 1 ranking from Euromonitor International for 2025, being recognized as the top Chinese brand in global life science laboratory equipment sales and in overseas sales within the same category. This achievement follows a successful three-phase international expansion, which has resulted in a compound annual growth rate exceeding 20 percent. The company's growth strategy included targeted projects with organizations like UNICEF and the World Health Organization, scaling its distribution network to 160 countries, and embedding full operational capabilities in key regions. Haier Biomedical now operates overseas R&D centers in the United Kingdom, Italy, and Japan. In Q1 2026, the company reported significant revenue growth, including over 50 percent in Germany, Australia, and Canada, and over 100 percent in Eastern Europe, South Asia, and Brazil. Haier Biomedical is also a part of the supply chains for leading pharmaceutical companies in countries such as Switzerland, Germany, Denmark, Italy, Singapore, the United States, Israel, and India, and its Ultra Energy series dominates the United States Energy Star rankings.